{"id":2398,"date":"2026-06-10T13:57:08","date_gmt":"2026-06-10T13:57:08","guid":{"rendered":"https:\/\/www.expedium.net\/blog\/?p=2398"},"modified":"2026-06-10T13:57:11","modified_gmt":"2026-06-10T13:57:11","slug":"the-prior-authorization-problem-whats-behind-the-wait-and-what-you-can-actually-do-about-it","status":"publish","type":"post","link":"https:\/\/www.expedium.net\/blog\/the-prior-authorization-problem-whats-behind-the-wait-and-what-you-can-actually-do-about-it\/","title":{"rendered":"The Prior Authorization Problem: What’s Behind the Wait and What You Can Actually Do About It"},"content":{"rendered":"\n

A Michigan patient was diagnosed with stage 1 tonsil cancer. His doctor ordered a PET scan immediately to determine the best treatment path. The insurer required prior authorization first. Three weeks passed. When the scan finally happened, the cancer had progressed to stage 2. That story was presented before the Michigan Senate not as a worst-case scenario, but as an example of what happens routinely, every single day, in practices across the country.<\/p>\n\n\n\n

This is the weight behind what most people dismiss as a billing inconvenience. Prior authorization <\/a>(PA) is not just a paperwork issue. It is a clinical reality with consequences that ripple from the waiting room to the operating table. And yet, for all the justified frustration around it, the process exists for reasons that are not entirely without merit. Understanding both sides of that story, and more importantly, knowing what your practice can do to cut through the delays, is what this blog is about.<\/p>\n\n\n\n

So Why Does Prior Authorization Exist at All?<\/h2>\n\n\n\n

It helps to step back and think about what prior authorization is actually trying to do, before deciding whether it is doing it well.<\/p>\n\n\n\n

Health insurers require PA as a checkpoint before covering certain treatments, medications, procedures, or diagnostic tests. The stated goals are reasonable enough: confirm that a proposed treatment is medically necessary, verify it aligns with clinical guidelines, check whether a lower-cost but equally effective alternative exists, and prevent dangerous drug interactions from slipping through.<\/p>\n\n\n\n

The process is especially applied to high-cost interventions, specialty medications, elective surgeries, durable medical equipment, and MRIs. From a payer’s standpoint, the logic is that spending 15 minutes reviewing a request could prevent an unnecessary $80,000 procedure. For a patient who genuinely does not need that procedure, the system arguably works.<\/p>\n\n\n\n

The problem is that it does not only stop unnecessary procedures. It stops necessary ones too.<\/p>\n\n\n\n

Where the Logic Breaks Down<\/h2>\n\n\n\n

A 2025 RAND Corporation commentary put it plainly: prior authorization “transcends mere administrative inconvenience; it poses a clinical risk.” Deferred care leads to worse outcomes and more expensive interventions down the line. Every hour a physician spends navigating insurer queues is an hour not spent on diagnosis, treatment, or counseling.<\/p>\n\n\n\n

The numbers behind this are striking. According to the Medical Group Management Association (MGMA)<\/a>, six in ten practices report that at least three employees are involved in completing a single PA request. Thirty-five percent say each request takes upward of 35 minutes on average. For independent practices and small rural clinics already operating on thin margins, that kind of drain is not sustainable.<\/p>\n\n\n\n

And when you are a small team and a prior authorization bounces back due to incomplete documentation, or a payer changes its criteria without much notice, or a fax never makes it to the right desk, the delay is not measured in minutes. It is measured in days, sometimes weeks. For a patient waiting on cancer imaging, a pain management procedure, or a psychiatric medication, that wait has real costs.<\/p>\n\n\n\n

The Real Burden Is Not Evenly Distributed<\/h2>\n\n\n\n

This is worth saying clearly: prior authorization hits smaller practices and underserved communities much harder than large hospital systems with dedicated authorization departments.<\/p>\n\n\n\n

A rural clinic with a two-person billing team cannot absorb the same volume of PA requests as a large health system with a centralized team of specialists. When staff time is finite and PA volume is high, something gives. Often, it is the follow-up that suffers, and requests that should have been approved sit stalled in a payer queue for days longer than necessary.<\/p>\n\n\n\n

According to research cited by rural healthcare analysts, up to 40% of providers have considered leaving practice entirely because of administrative burdens like prior authorization. That is not burnout in the abstract. That is provider shortages in the communities that can least afford them.<\/p>\n\n\n\n

What Is Actually Driving the Delays (And What Is Not)<\/h2>\n\n\n\n

Not all delays come from insurer slowness. Plenty originate on the provider side, and being honest about that is important for fixing them. The most common causes include:<\/p>\n\n\n\n

Incomplete submissions.<\/strong> A missing referral letter, an unclear clinical note, or the wrong diagnosis code<\/a> and treatment history can send a request back to square one. Most denials on this basis are avoidable with better internal checklists.<\/p>\n\n\n\n

Policy changes that went unnoticed.<\/strong> Payers update their PA criteria regularly. A treatment that did not require authorization six months ago may require it now. Practices that do not stay current on payer policy get caught off guard on submission day.<\/p>\n\n\n\n

Manual, paper-based workflows.<\/strong> Fax-based submissions are slow, hard to track, and easy to lose. There is no real-time visibility into where a request stands, which means follow-up gets delayed or forgotten entirely.<\/p>\n\n\n\n

Payer specific requirements. <\/strong>Different payers may require different forms, clinical criteria, submission methods, review process.<\/p>\n\n\n\n

No designated ownership.<\/strong> When prior authorization is “everyone’s job,” it tends to become no one’s priority. Without a named person or team responsible for tracking each request through to approval, things fall through.<\/p>\n\n\n\n

Insufficient clinical documentation.<\/strong> Insurers want to see that the clinical case for the requested service has been made clearly. Vague or generic notes do not hold up well under medical necessity review.<\/p>\n\n\n\n

Practical Ways to Cut Through the Delays<\/h2>\n\n\n\n

None of these require a massive overhaul. They are process changes that most practices can begin implementing fairly quickly.<\/p>\n\n\n\n

Start earlier.<\/strong> Check authorization requirements at the time of scheduling, not the day before the appointment. Insurance eligibility verification<\/a> tools that flag which services need PA give your team lead time to act before the clock becomes a problem.<\/p>\n\n\n\n

Build payer-specific submission templates.<\/strong> Each major payer has its own documentation requirements and criteria. Templates that capture every required field for each payer reduce back-and-forth submissions significantly.<\/p>\n\n\n\n

Assign ownership.<\/strong> Designate someone in the practice who is responsible for tracking open PA requests, following up with payers at regular intervals, and flagging anything that has been pending too long. Accountability matters more than headcount.<\/p>\n\n\n\n

Move to electronic PA submission.<\/strong> The shift to electronic prior authorization (ePA) is not optional much longer. CMS has set a 2026 mandate for Medicare Advantage and Medicaid plans to support electronic PA via FHIR-based APIs. Practices that adopt ePA systems now, before the mandate takes full effect, gain faster turnaround times and real-time status tracking that manual processes simply cannot match.<\/p>\n\n\n\n

Track High-Risk Procedures and Payers. <\/strong>Analyze historical denial and authorization data to identify:<\/p>\n\n\n\n